FIELD: organic chemistry, medicine, pharmacy.
SUBSTANCE: invention describes derivatives of 4-phenylpyridine of the following general formulae: (IA)
and (IB) wherein R1 means and , or -NH(CH2)2OH, -NR3C(O)CH3 or -NR3C(O)-cyclopropyl; R2 means methyl or chlorine atom; R3 means hydrogen atom or methyl; R means hydrogen atom or -(CH2)2OH; n = 1 or 2, and their pharmaceutically acceptable acid-additive salts. Also, invention describes a medicinal agent possessing effect of agonist of NK-1 receptors based on these compounds. Proposed compounds show good affinity degree to NK-1 receptors and can be used in treatment or prophylaxis of diseases associated with these receptors.
EFFECT: valuable medicinal properties of compounds and agent.
10 cl, 1 tbl, 14 ex
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF 4-PHENYLPYRIDINE N-OXIDES, MEDICINAL AGENT COMPRISING THEREOF | 2001 |
|
RU2266284C2 |
APPLICATION OF RECEPTOR NK-1 ANTAGONISTS FOR TREATING CRANIOCEREBRAL AND SPINAL TRAUMAS OR NERVOUS TISSUE LESION | 2002 |
|
RU2304435C2 |
DERIVATIVES OF 4-PHENYLPYRIDINE AND MEDICINAL AGENT BASED ON THEREOF | 2001 |
|
RU2277087C2 |
NK1/NK3 DOUBLE AGONISTS FOR TREATING SCHIZOPHRENIA | 2004 |
|
RU2347777C2 |
DERIVATIVES OF 5-PHENYLPYRIMIDINE AND PHARMACEUTICAL COMPOSITION | 2000 |
|
RU2244710C2 |
DERIVATIVES OF PYRIMIDINE AND PHARMACEUTICAL COMPOSITION | 2001 |
|
RU2284997C2 |
DERIVATIVES OF 3-PHENYLPYRIDINE AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2000 |
|
RU2236402C2 |
DERIVATIVES OF BENZENE OR PYRIDINE AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2000 |
|
RU2238264C2 |
PYRROLIDINE DERIVATIVES | 2010 |
|
RU2562605C2 |
PYRROLIDINE DERIVATIVES AS NK-3 RECEPTOR ANTAGONISTS | 2010 |
|
RU2561271C2 |
Authors
Dates
2006-05-10—Published
2001-07-20—Filed